Ryan Maynard - Sep 12, 2022 Form 3 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Chief Financial Officer
Signature
/s/ Darren DeStefano, Attorney in Fact
Stock symbol
CARA
Transactions as of
Sep 12, 2022
Transactions value $
$0
Form type
3
Date filed
9/14/2022, 04:40 PM
Previous filing
Jun 14, 2022
Next filing
Mar 3, 2023

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned